Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans

Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images

Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888 · see citing works

AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages

Cox, R. W. (1996) · Computers and Biomedical Research · doi:10.1006/cbmr.1996.0014 · Cited by 10,913 · see citing works

Fast robust automated brain extraction

Smith, S. M. (2002) · Human Brain Mapping · doi:10.1002/hbm.10062 · Cited by 10,496 · see citing works

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

Temporal Autocorrelation in Univariate Linear Modeling of FMRI Data

Woolrich, M. W., Ripley, B. D., Brady, M., & Smith, S. M. (2001) · NeuroImage · doi:10.1006/nimg.2001.0931 · Cited by 2,859 · see citing works

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works

The primate basal ganglia: Parallel and integrative networks

Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479 · see citing works

NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · see citing works

Magical ideation as an indicator of schizotypy.

Eckblad, M., & Chapman, L. J. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.51.2.215 · Cited by 1,155 · see citing works

Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats

Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006 · see citing works

Magical ideation as an indicator of schizotypy.

Eckblad, M., & Chapman, L. J. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.2.215 · Cited by 885 · see citing works

Body-image aberration in schizophrenia.

Chapman, L. J., Chapman, J. P., & Raulin, M. L. (1978) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.87.4.399 · Cited by 854 · see citing works

Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man

Domino, E. F., Chodoff, P., & Corssen, G. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196563279 · Cited by 753 · see citing works

Body-image aberration in schizophrenia.

Chapman, L. J., Chapman, J. P., & Raulin, M. L. (1978) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.87.4.399 · Cited by 743 · see citing works

Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition

Royer, S., Zemelman, B. V., Losonczy, A., Kim, J., Chance, F., Magee, J. C., & Buzsáki, G. (2012) · Nature Neuroscience · doi:10.1038/nn.3077 · Cited by 728 · see citing works

The cortico-basal ganglia integrative network: The role of the thalamus

Haber, S. N., & Calzavara, R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.09.013 · Cited by 721 · see citing works

Global Connectivity of Prefrontal Cortex Predicts Cognitive Control and Intelligence

Cole, M. W., Yarkoni, T., Repovs, G., Anticevic, A., & Braver, T. S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0536-12.2012 · Cited by 613 · see citing works

Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia

Peralta, V., & Cuesta, M. J. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90093-0 · Cited by 583 · see citing works

Identifying the brain's most globally connected regions

Cole, M. W., Pathak, S., & Schneider, W. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.001 · Cited by 557 · see citing works

NMDA-dependent modulation of CA1 local circuit inhibition

Grunze, H., Rainnie, D., Hasselmo, M., Barkai, E., Hearn, E., McCarley, R., & Greene, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02034.1996 · Cited by 467 · see citing works

Ketamine activates psychosis and alters limbic blood flow in schizophrenia

Lahti, A. C., Holcomb, H. H., Medoff, D. R., & Tamminga, C. A. (1995) · Neuroreport · doi:10.1097/00001756-199504190-00011 · Cited by 434 · see citing works

NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex

Jackson, M. E., Homayoun, H., & Moghaddam, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308455101 · Cited by 430 · see citing works

Five-component model of schizophrenia: Assessing the factorial invariance of the positive and negative syndrome scale

Bell, M. D., Lysaker, P. H., Goulet, J. L., Milstein, R. M., & Lindenmayer, J. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90075-2 · Cited by 422 · see citing works

Regulation of neuronal input transformations by tunable dendritic inhibition

Lovett-Barron, M., Turi, G. F., Kaifosh, P., Lee, P. H., Bolze, F., Sun, X.-H., Nicoud, J.-F., Zemelman, B. V., Sternson, S. M., & Losonczy, A. (2012) · Nature Neuroscience · doi:10.1038/nn.3024 · Cited by 417 · see citing works

Toward a neurobiology of delusions

Corlett, P. R., Taylor, J. R., Wang, X.-J., Fletcher, P. C., & Krystal, J. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.007 · Cited by 394 · see citing works

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.805 · Cited by 392 · see citing works

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)

Vollenweider, F. X., Leenders, K. L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00039-9 · Cited by 353 · see citing works

Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine: Implications for Glutamatergic and Dopaminergic Model Psychoses and Cognitive Function

Krystal, J. H., Perry, E. B., Gueorguieva, R., Belger, A., Madonick, S. H., Abi-Dargham, A., Cooper, T. B., MacDougall, L., Abi-Saab, W., & D’Souza, D. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.985 · Cited by 317 · see citing works

N-Methyl d-Aspartate Receptor Antagonists Ketamine and MK-801 Induce Wake-Related Aberrant γ Oscillations in the Rat Neocortex

Pinault, D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.006 · Cited by 315 · see citing works

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology

Stone, J. M., Dietrich, C., Edden, R., Mehta, M. A., De Simoni, S., Reed, L. J., Krystal, J. H., Nutt, D., & Barker, G. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.171 · Cited by 295 · see citing works

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1982-8 · Cited by 272 · see citing works

Five-Factor Model of Schizophrenia Initial Validation

LINDENMAYER, J.-P., Bernstein-Hyman, R., & Grochowski, S. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199411000-00006 · Cited by 259 · see citing works

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans

Krystal, J. H., D’Souza, D. C., Karper, L. P., Bennett, A., Abi‐Dargham, A., Abi‐Saab, D., Cassello, K., Bowers, M. B., Vegso, S., Heninger, G. R., et al. (1999) · Psychopharmacology · doi:10.1007/s002130051049 · Cited by 243 · see citing works

Variable Global Dysconnectivity and Individual Differences in Schizophrenia

Cole, M. W., Anticevic, A., Repovš, G., & Barch, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.010 · Cited by 227 · see citing works

NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness

Hakami, T. M., Jones, N. C., Tolmacheva, E. A., Gaudias, J., Chaumont, J., Salzberg, M. R., O'Brien, T. J., & Pinault, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006755 · Cited by 222 · see citing works

Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications

Carlsson, A., Hansson, L. O., Waters, N., & Carlsson, M. L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00228-2 · Cited by 187 · see citing works

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

Krystal, J. H., Karper, L. P., Bennett, A., D’Souza, D. C., Abi‐Dargham, A., Morrissey, K., Abi‐Saab, D., Bremner, J. D., Bowers, M. B., Suckow, R. F., et al. (1998) · Psychopharmacology · doi:10.1007/s002130050503 · Cited by 184 · see citing works

N-methyl-d-aspartic acid receptor antagonist–induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia

Ehrlichman, R. S., Gandal, M. J., Maxwell, C. R., Lazarewicz, M. T., Finkel, L. H., Contreras, D., Turetsky, B. I., & Siegel, S. J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.031 · Cited by 171 · see citing works

Relationship between the corticostriatal terminals from areas 9 and 46, and those from area 8A, dorsal and rostral premotor cortex and area 24c: an anatomical substrate for cognition to action

Calzavara, R., Mailly, P., & Haber, S. N. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05825.x · Cited by 170 · see citing works

Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation

Hoffman, R. E., Hampson, M., Wu, K., Anderson, A. W., Gore, J. C., Buchanan, R. J., Constable, R. T., Hawkins, K. A., Sahay, N., & Krystal, J. H. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl183 · Cited by 169 · see citing works

Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS Dynamically

Holcomb, H. H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00229-9 · Cited by 157 · see citing works

Disruption of Prefrontal Cortex Large Scale Neuronal Activity by Different Classes of Psychotomimetic Drugs

Wood, J. T., Kim, Y., & Moghaddam, B. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6377-11.2012 · Cited by 148 · see citing works

Comparison of Sernyl with Other Drugs

Rosenbaum, G. (1959) · A M A Archives of General Psychiatry · doi:10.1001/archpsyc.1959.03590060113013 · Cited by 141 · see citing works

Activation of Metabotropic Glutamate 2/3 Receptors Reverses the Effects of NMDA Receptor Hypofunction on Prefrontal Cortex Unit Activity in Awake Rats

Homayoun, H., Jackson, M., & Moghaddam, B. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00875.2004 · Cited by 137 · see citing works

Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex

Yonezawa, Y., Kuroki, T., Kawahara, T., Tashiro, N., & Uchimura, H. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01435-0 · Cited by 133 · see citing works

Comparison of Phencyclidine Hydrochloride (Sernyl) with Other Drugs

Cohen, B. D. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01710230063007 · Cited by 131 · see citing works

Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research

Vollenweider, F. X. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979353 · Cited by 130 · see citing works

Positive and Negative Syndrome Scale

Kay, S. R., Opler, L. A., & Fiszbein, A. (2012) · PsycTESTS Dataset · doi:10.1037/t05056-000 · Cited by 129 · see citing works

Control of Feedforward Dendritic Inhibition by NMDA Receptor-Dependent Spike Timing in Hippocampal Interneurons

Maccaferri, G., & Dingledine, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05462.2002 · Cited by 121 · see citing works

Diminished Orientation-Specific Surround Suppression of Visual Processing in Schizophrenia

Yoon, J. H., Rokem, A., Silver, M. A., Minzenberg, M., Ursu, S., Ragland, J. D., & Carter, C. S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp064 · Cited by 114 · see citing works

Effects of Noncompetitive NMDA Receptor Blockade on Anterior Cingulate Cerebral Blood Flow in Volunteers with Schizophrenia

Holcomb, H. H., Lahti, A. C., Medoff, D. R., Cullen, T. J., & Tamminga, C. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300824 · Cited by 108 · see citing works

Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study

Stone, J. M., Erlandsson, K., Arstad, E., Squassante, L., Teneggi, V., Bressan, R. A., Krystal, J. H., Ell, P. J., & Pilowsky, L. S. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1047-x · Cited by 103 · see citing works

Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats

Amitai, N., Kuczenski, R. T., Behrens, M. M., & Markou, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.008 · Cited by 92 · see citing works

NMDA receptor related agents : biochemistry, pharmacology and behavior

亀山, 勉., Domino, E. F., & 鍋島, 俊. (1991) · Cited by 88 · see citing works

Neurobiology of Mental Illness

Dünner, D. L. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1530-a · Cited by 79 · see citing works

Functional connectivity studies of patients with auditory verbal hallucinations

Hoffman, R. E., & Hampson, M. (2012) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2012.00006 · Cited by 72 · see citing works

Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS)

BRYSON, G. J., Bell, M. D., Greig, T. C., & Kaplan, E. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00004-3 · Cited by 60 · see citing works

Inhibition of mammalian brain acetylcholinesterase by ketamine

Cohen, M. L., Chan, S.-L., Bhargava, H. N., & Trevor, A. J. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90377-3 · Cited by 58 · see citing works

Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase

Dollfus, S., & Petit, M. (1995) · European Psychiatry · doi:10.1016/0924-9338(96)80320-8 · Cited by 57 · see citing works

Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism

Krystal, J. H., Madonick, S. H., Perry, E. B., Gueorguieva, R. V., Brush, L., Wray, Y., Belger, A., & D’Souza, D. C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300994 · Cited by 56 · see citing works

The chiral forms of ketamine as probes for NMDA receptor functions in humans

Øye, I., Hustveit, O., Maurset, A., Er, M., Paulsen, O., & La, S. (1991) · Cited by 41 · see citing works

Principal-component analysis of PANSS and SANS - SAPS global ratings in schizophrenic patients

Dollfus, S., Petit, M., Lesieur, P., & Ménard, J.-F. (1991) · European Psychiatry · doi:10.1017/s0924933800003886 · Cited by 38 · see citing works

Reversal of Ketamine-Induced Working Memory Impairments by the GABAAα2/3 Agonist TPA023

Castner, S. A., Arriza, J. L., Roberts, J. C., Mrzljak, L., Christian, E. P., & Williams, G. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.001 · Cited by 37 · see citing works

KETAMINE INTERACTS WITH OPIATE RECEPTORS AS AN AGONIST

Smith, D. J., Westfall, D. P., & Adams, J. D. (1980) · Anesthesiology · doi:10.1097/00000542-198009001-00005 · Cited by 26 · see citing works

Positive and Negative Syndrome Scale-6

Østergaard, S. D., Lemming, O. M., Mors, O. N., Correll, C. U., & Bech, P. (2016) · PsycTESTS Dataset · doi:10.1037/t52718-000 · Cited by 25 · see citing works

Erratum: Corrigendum: Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition

Royer, S., Zemelman, B. V., Losonczy, A., Kim, J., Chance, F. S., Magee, J. C., & Buzsáki, G. (2013) · Nature Neuroscience · doi:10.1038/nn1213-1907b · Cited by 2 · see citing works

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026 · see citing works

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., Seifritz, E., Repovs, G., Krystal, J. H., Murray, J. D., et al. (2018) · eLife · doi:10.7554/elife.35082 · Cited by 390 · see citing works

Reviewing the ketamine model for schizophrenia

Frohlich, J., & Van Horn, J. D. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113512909 · Cited by 303 · see citing works

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., DeWilde, K. E., Wong, E., Anticevic, A., Tang, C. Y., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.186 · Cited by 300 · see citing works

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283 · see citing works

Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder

Anticevic, A., Hu, S., Zhang, S., Savic, A., Billingslea, E., Wasylink, S., Repovs, G., Cole, M. W., Bednarski, S., Krystal, J. H., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.021 · Cited by 268 · see citing works

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects

Nugent, A. C., Ballard, E. D., Gould, T. D., Park, L. T., Moaddel, R., Brutsche, N. E., & Zarate, C. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0028-2 · Cited by 250 · see citing works

Neuroimaging Biomarkers in Schizophrenia

Kraguljac, N. V., McDonald, W. M., Widge, A. S., Rodríguez, C. I., Tohen, M. F., & Nemeroff, C. B. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20030340 · Cited by 244 · see citing works

Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans

Muthukumaraswamy, S. D., Shaw, A. D., Jackson, L. E., Hall, J., Moran, R., & Saxena, N. K. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0903-15.2015 · Cited by 230 · see citing works

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects

Abdallah, C. G., De Feyter, H. M., Averill, L. A., Jiang, L., Averill, C. L., Chowdhury, G. M. I., Purohit, P., de Graaf, R. A., Esterlis, I., Juchem, C., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0136-3 · Cited by 229 · see citing works

The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia

Cohen, S. M., Tsien, R. W., GOFF, D. C., & Halassa, M. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.026 · Cited by 233 · see citing works

Large-scale functional connectivity networks in the rodent brain

Gozzi, A., & Schwarz, A. J. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.12.017 · Cited by 214 · see citing works

Anti-NMDA receptor encephalitis, autoimmunity, and psychosis

Kayser, M. S., & Dalmau, J. O. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.007 · Cited by 224 · see citing works

The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?

Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.010 · Cited by 219 · see citing works

Chronnectome fingerprinting: Identifying individuals and predicting higher cognitive functions using dynamic brain connectivity patterns

Liu, J., Liao, X., Xia, M., & Yong He, A. (2017) · Human Brain Mapping · doi:10.1002/hbm.23890 · Cited by 205 · see citing works

Resting-state network-specific breakdown of functional connectivity during ketamine alteration of consciousness in volunteers

Bonhomme, V., Vanhaudenhuyse, A., Demertzi, A., Bruno, M.-A., Jaquet, O., Bahri, M. A., Plenevaux, A., Boly, M., Boveroux, P., Soddu, A., et al. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001275 · Cited by 207 · see citing works

Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective

Krystal, J. H., Anticevic, A., Yang, G., Dragoi, G., Driesen, N. R., Wang, X., & Murray, J. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.004 · Cited by 195 · see citing works

Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity

Preller, K. H., Duerler, P., Burt, J. B., Ji, J. L., Adkinson, B. D., Stämpfli, P., Seifritz, E., Repovš, G., Krystal, J. H., Murray, J. D., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.12.027 · Cited by 180 · see citing works

Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia

Beck, K., Hindley, G., Borgan, F., Ginestet, C. E., McCutcheon, R. A., Brugger, S. P., Driesen, N. R., Ranganathan, M., D’Souza, D. C., Taylor, M. J., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.4693 · Cited by 184 · see citing works

N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia

Anticevic, A., Corlett, P. R., Cole, M. W., Savic, A., Gancsos, M., Tang, Y., Repovs, G., Murray, J. D., Driesen, N. R., Morgan, P. T., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.022 · Cited by 181 · see citing works

Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change

Anticevic, A., Hu, X., Xiao, Y., Hu, J., Li, F., Bi, F., Cole, M. W., Savic, A., Yang, G. J., Repovs, G., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2310-14.2015 · Cited by 178 · see citing works

Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration

Evans, J. W., Szczepanik, J., Brutsché, N., Park, L. T., Nugent, A. C., & Zarate, C. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.027 · Cited by 173 · see citing works

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages

Grent-‘t-Jong, T., Groß, J., Goense, J. B. M., Wibral, M., Gajwani, R., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., Schröder, T. N., et al. (2018) · eLife · doi:10.7554/elife.37799 · Cited by 161 · see citing works

Save the Global: Global Signal Connectivity as a Tool for Studying Clinical Populations with Functional Magnetic Resonance Imaging

Hahamy, A., Calhoun, V. D., Pearlson, G. D., Harel, M., Stern, N., Attar, F., Malach, R., & Salomon, R. (2014) · Brain Connectivity · doi:10.1089/brain.2014.0244 · Cited by 164 · see citing works

Ketamine for the treatment of addiction: evidence and potential mechanisms

Ivan Ezquerra-Romano, I., Lawn, W., Krupitsky, E., & Morgan, C. J. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.017 · Cited by 163 · see citing works

Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

Sanacora, G., & Schatzberg, A. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.261 · Cited by 160 · see citing works

New targets for rapid antidepressant action

Machado‐Vieira, R., Henter, I. D., & Zarate, C. A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.001 · Cited by 156 · see citing works

Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function

Duman, R. S., Shinohara, R., Fogaça, M. V., & Hare, B. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0400-x · Cited by 155 · see citing works

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression

Esterlis, I., DellaGioia, N., Pietrzak, R. H., Matuskey, D., Nabulsi, N., Abdallah, C. G., Yang, J., Pittenger, C., Sanacora, G., Krystal, J. H., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.58 · Cited by 148 · see citing works

The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity

Driesen, N. R., McCarthy, G., Bhagwagar, Z., Bloch, M. H., Calhoun, V. D., D'Souza, D. C., Gueorguieva, R., He, G., Leung, H.-C., Ramani, R., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.170 · Cited by 148 · see citing works

Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical–Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings

Rivolta, D., Heidegger, T., Scheller, B., Sauer, A., Schaum, M., Birkner, K., Singer, W., Wibral, M., & Uhlhaas, P. J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv051 · Cited by 145 · see citing works

Substance-Induced Psychoses: An Updated Literature Review

Fiorentini, A., Cantù, F., Crisanti, C., Cereda, G., Oldani, L., & Brambilla, P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.694863 · Cited by 146 · see citing works

Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings

Northoff, G., & Sibille, E. L. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.68 · Cited by 145 · see citing works

Drug models of schizophrenia

Steeds, H., Carhart-Harris, R. L., & Stone, J. M. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314557797 · Cited by 134 · see citing works

Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia

Höflich, A. S., Hahn, A., Küblböck, M., Kranz, G. S., Vanicek, T., Windischberger, C., Saria, A., Kasper, S. F., Winkler, D., & Lanzenberger, R. R. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv040 · Cited by 125 · see citing works

Altered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration

Lorenzo, G. D., Daverio, A., Ferrentino, F., Santarnecchi, E., Ciabattini, F., Monaco, L., Lisi, G., Barone, Y., Lorenzo, C. D., Niolu, C., et al. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00234 · Cited by 118 · see citing works

The Relationship between Glucose Metabolism, Resting-State fMRI BOLD Signal, and GABA A -Binding Potential: A Preliminary Study in Healthy Subjects and Those with Temporal Lobe Epilepsy

Nugent, A. C., Martinez, A. R., D'Alfonso, A., Zarate, C. A., & Theodore, W. H. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.228 · Cited by 120 · see citing works

Ketamine-Induced Hallucinations

Powers, A. R., Gancsos, M. G., Finn, E. S., MORGAN, P. T., & Corlett, P. R. (2015) · Psychopathology · doi:10.1159/000438675 · Cited by 118 · see citing works

Dopamine homeostasis brain functional connectivity in reward deficiency syndrome

Blum, K. (2016) · Frontiers in bioscience · doi:10.2741/4509 · Cited by 115 · see citing works

General Anesthesia: A Probe to Explore Consciousness

Bonhomme, V. L., Staquet, C., Montupil, J., Defresne, A., Kirsch, M., Martial, C., Vanhaudenhuyse, A., Chatelle, C., Larroque, S. K., Raimondo, F., et al. (2019) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2019.00036 · Cited by 112 · see citing works

Mediodorsal and Visual Thalamic Connectivity Differ in Schizophrenia and Bipolar Disorder With and Without Psychosis History

Anticevic, A., Yang, G. R., Savić, A., Murray, J. D., Cole, M. W., Repovš, G., Pearlson, G. D., & Glahn, D. C. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu100 · Cited by 111 · see citing works

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals

Mkrtchian, A., Evans, J. W., Kraus, C., Yuan, P., Kadriu, B., Nugent, A. C., Roiser, J. P., & Zarate, C. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00878-1 · Cited by 110 · see citing works

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia

Nakazawa, K., Jeevakumar, V., & Nakao, K. (2017) · npj Schizophrenia · doi:10.1038/s41537-016-0003-3 · Cited by 110 · see citing works

Classics in Chemical Neuroscience: Ketamine

Tyler, M. W., Yourish, H. B., Ionescu, D. F., & Haggarty, S. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00074 · Cited by 106 · see citing works

In Vivo Ketamine-Induced Changes in [ 11 C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5

DeLorenzo, C., DellaGioia, N., Bloch, M. H., Sanacora, G., Nabulsi, N., Abdallah, C. G., Yang, J., Wen, R., Mann, J. J., Krystal, J. H., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.024 · Cited by 105 · see citing works

Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat

Gass, N., Schwarz, A. J., Sartorius, A., Schenker, E., Risterucci, C., Spedding, M., Zheng, L., Meyer‐Lindenberg, A., & Weber‐Fahr, W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.290 · Cited by 104 · see citing works

Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder

Nugent, A. C., Robinson, S. E., Coppola, R., Furey, M. L., & Zarate, C. A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.05.051 · Cited by 103 · see citing works

Functional geometry of the cortex encodes dimensions of consciousness

Huang, Z., Mashour, G. A., & Hudetz, A. G. (2023) · Nature Communications · doi:10.1038/s41467-022-35764-7 · Cited by 101 · see citing works

Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers

Kraguljac, N. V., Frölich, M. A., Tran, S., White, D. M., Nichols, N., Barton-McArdle, A., Reid, M. A., Bolding, M., & Lahti, A. C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.122 · Cited by 101 · see citing works

Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone

Kraguljac, N. V., White, D. M., Hadley, J. A., Visscher, K., Knight, D. C., Hoef, L. V., Falola, B., & Lahti, A. C. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.11.015 · Cited by 99 · see citing works

The Whole-Brain “Global” Signal from Resting State fMRI as a Potential Biomarker of Quantitative State Changes in Glucose Metabolism

Thompson, G. J., Riedl, V., Grimmer, T., Drzezga, A. E., Hermán, P., & Hyder, F. (2016) · Brain Connectivity · doi:10.1089/brain.2015.0394 · Cited by 92 · see citing works

Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats

Grimm, O., Gass, N., Weber‐Fahr, W., Sartorius, A., Schenker, E., Spedding, M., Risterucci, C., Schweiger, J. I., Böhringer, A., Zang, Z., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4022-y · Cited by 91 · see citing works

The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.

Amidfar, M., Woelfer, M., Réus, G. Z., Quevedo, J., Walter, M., & Kim, Y.-K. (2019) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109668 · Cited by 86 · see citing works

Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans

Farnes, N., Juel, B. E., Nilsen, A. S., Romundstad, L. G., & Storm, J. F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242056 · Cited by 78 · see citing works

Decreased directed functional connectivity in the psychedelic state

Barnett, L., Muthukumaraswamy, S. D., Carhart-Harris, R. L., & Seth, A. K. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116462 · Cited by 79 · see citing works

Connectivity, Pharmacology, and Computation: Toward a Mechanistic Understanding of Neural System Dysfunction in Schizophrenia

Anticevic, A., Cole, M. W., Repovš, G., Savić, A., Driesen, N. R., Yang, G., Cho, Y., Murray, J. D., Glahn, D. C., Wang, X., et al. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00169 · Cited by 78 · see citing works

Ketamine induces a robust whole-brain connectivity pattern that can be differentially modulated by drugs of different mechanism and clinical profile

Joules, R., Doyle, O., Schwarz, A. J., O’Daly, O., Brammer, M. J., Williams, S., & Mehta, M. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3951-9 · Cited by 76 · see citing works

Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task

Carli, M., & Invernizzi, R. W. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00058 · Cited by 74 · see citing works

Aberrant maturation and connectivity of prefrontal cortex in schizophrenia—contribution of NMDA receptor development and hypofunction

Gao, W., Yang, S.-S., Mack, N. R., & Chamberlin, L. A. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01196-w · Cited by 70 · see citing works

Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach

Abdallah, C. G., Wrocklage, K. M., Averill, C. L., Akiki, T. J., Schweinsburg, B. C., Roy, A. M., Martini, B. A., Southwick, S. M., Krystal, J. H., & Scott, J. C. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.12 · Cited by 69 · see citing works

Biomarkers, designs, and interpretations of resting‐state fMRI in translational pharmacological research: A review of state‐of‐the‐Art, challenges, and opportunities for studying brain chemistry

Khalili‐Mahani, N., Rombouts, S. A. R. B., van Osch, M. J. P., Duff, E. P., Carbonell, F., Nickerson, L. D. H., Becerra, L. R., Dahan, A., Evans, A. C., Soucy, J., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23516 · Cited by 61 · see citing works

Biophysical Modeling of Large-Scale Brain Dynamics and Applications for Computational Psychiatry

Murray, J. D., Demirtaş, M., & Anticevic, A. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.07.004 · Cited by 67 · see citing works

Pharmacological fMRI: Effects of subanesthetic ketamine on resting-state functional connectivity in the default mode network, salience network, dorsal attention network and executive control network

Müller, F., Musso, F., London, M. K., de Boer, P., Zacharias, N., & Winterer, G. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.05.037 · Cited by 64 · see citing works

Functional connectivity and activity of white matter in somatosensory pathways under tactile stimulations

Wu, X., Yang, Z., Bailey, S., Zhou, J., Cutting, L. E., Gore, J. C., & Ding, Z. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.074 · Cited by 63 · see citing works

Disruption of Conscious Access in Schizophrenia

Berkovitch, L., Dehaene, S., & Gaillard, R. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.08.006 · Cited by 60 · see citing works

Do NMDA-R antagonists re-create patterns of spontaneous gamma-band activity in schizophrenia? A systematic review and perspective

Bianciardi, B., & Uhlhaas, P. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.005 · Cited by 60 · see citing works

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives

Pallavicini, C., Vilas, M. G., Villarreal, M. F., Zamberlán, F., Muthukumaraswamy, S. D., Nutt, D., Carhart-Harris, R. L., & Tagliazucchi, E. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.053 · Cited by 55 · see citing works

Animal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant?

Swerdlow, N. R., & Light, G. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5012 · Cited by 58 · see citing works

Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia

Ramos‐Miguel, A., Beasley, C. L., Dwork, A. J., Mann, J. J., Rosoklija, G. B., Barr, A. M., & Honer, W. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.012 · Cited by 58 · see citing works

The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain

Montani, C., Canella, C., Schwarz, A. J., Li, J., Gilmour, G., Galbusera, A., Wafford, K. A., Gutierrez‐Barragan, D., McCarthy, A. P., Shaw, D. B., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00916-0 · Cited by 55 · see citing works

MK-801 disrupts and nicotine augments 40 Hz auditory steady state responses in the auditory cortex of the urethane-anesthetized rat

Sivarao, D. V., Frenkel, M. Y., Chen, P., Healy, F. L., Lodge, N. J., & Zaczek, R. C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.006 · Cited by 55 · see citing works

mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions

Jin, L. E., Wang, M., Yang, S.-T., Yang, Y., Galvin, V. C., Lightbourne, T. C., Ottenheimer, D. J., Zhong, Q., Stein, J., Raja, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.129 · Cited by 57 · see citing works

An integrated network model of psychotic symptoms

Looijestijn, J., Blom, J. D., Aleman, A., Hoek, H. W., & Goekoop, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.016 · Cited by 55 · see citing works

The Pharmacology of Visual Hallucinations in Synucleinopathies

Russo, M., Carrarini, C., Dono, F., Rispoli, M. G., Pietro, M. D., Stefano, V. D., Ferri, L., Bonanni, L., Sensi, S. L., & ONOFRJ, M. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01379 · Cited by 56 · see citing works

The neurophysiology of ketamine: an integrative review

McMillan, R. L., & Muthukumaraswamy, S. D. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0090 · Cited by 49 · see citing works

Glutamatergic Deficits in Schizophrenia – Biomarkers and Pharmacological Interventions within the Ketamine Model

Haaf, M., Leicht, G., Ćurić, S., & Mulert, C. (2018) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201019666180620112528 · Cited by 51 · see citing works

Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action

Maltbie, E. A., Gopinath, K., & Howell, L. L. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000354 · Cited by 49 · see citing works

Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia

Abram, S. V., Roach, B. J., Fryer, S. L., Calhoun, V. D., Preda, A., van Erp, T. G. M., Bustillo, J., Lim, K. O., Loewy, R. L., Stuart, B. K., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01502-0 · Cited by 49 · see citing works

Bridging Levels of Understanding in Schizophrenia Through Computational Modeling

Anticevic, A., Murray, J. D., & Barch, D. M. (2015) · Clinical Psychological Science · doi:10.1177/2167702614562041 · Cited by 47 · see citing works

Ketamine interactions with biomarkers of stress: A randomized placebo-controlled repeated measures resting-state fMRI and PCASL pilot study in healthy men

Khalili‐Mahani, N., Niesters, M., van Osch, M. J. P., Oitzl, M. S., Veer, I. M., de Rooij, M., van Gerven, J., van Buchem, M. A., Beckmann, C. F., Rombouts, S. A. R. B., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.12.050 · Cited by 50 · see citing works

Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery

Nathan, P. J., Phan, K. L., Harmer, C. J., Mehta, M. A., & Bullmore, E. T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.11.009 · Cited by 48 · see citing works

Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models

Shah, U. H., & González-Maeso, J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00044 · Cited by 44 · see citing works

Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations

Anderson, P., Pinault, D., O'Brien, T. J., & Jones, N. C. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000959 · Cited by 45 · see citing works

Ketamine and international regulations

Liao, Y., Tang, Y., & Hao, W. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1278449 · Cited by 47 · see citing works

Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis

Dandash, O., Harrison, B. J., Adapa, R., Raphaël Gaillard, B., Giorlando, F., Wood, S. J., Fletcher, P. C., & Fornito, A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.210 · Cited by 46 · see citing works

Ketamine-dependent neuronal activation in healthy volunteers

Höflich, A. S., Hahn, A., Küblböck, M., Kranz, G. S., Vanicek, T., Ganger, S., Spies, M., Windischberger, C., Kasper, S. F., Winkler, D., et al. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1291-0 · Cited by 45 · see citing works

Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder

Nugent, A. C., Robinson, S. E., Coppola, R., & Zarate, C. A. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.06.006 · Cited by 42 · see citing works

Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder

Davis, M. T., DellaGiogia, N., Maruff, P., Pietrzak, R. H., & Esterlis, I. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01327-5 · Cited by 37 · see citing works

Ketamine-induced changes in connectivity of functional brain networks in awake female nonhuman primates: a translational functional imaging model

Gopinath, K., Maltbie, E. A., Urushino, N., Kempf, D., & Howell, L. L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4401-z · Cited by 39 · see citing works

Differences between ketamine’s short-term and long-term effects on brain circuitry in depression

Gass, N., Becker, R., Reinwald, J., Cosa‐Linan, A., Sack, M., Weber‐Fahr, W., Vollmayr, B., & Sartorius, A. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0506-6 · Cited by 41 · see citing works

Connectomic Underpinnings of Working Memory Deficits in Schizophrenia: Evidence From a replication fMRI study

Yang, J., Pu, W., Wu, G., Chen, E. Y. H., Lee, E. H. M., Liu, Z., & Palaniyappan, L. K. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz137 · Cited by 39 · see citing works

Salience Network Disruption in U.S. Army Soldiers With Posttraumatic Stress Disorder

Abdallah, C. G., Averill, C. L., Ramage, A. E., Averill, L. A., Goktas, S., Nemati, S., Krystal, J. H., Roache, J. D., Resick, P. A., Young‐McCaughan, S., et al. (2019) · Chronic Stress · doi:10.1177/2470547019850467 · Cited by 36 · see citing works

Reverse Translation of Clinical Electrophysiological Biomarkers in Behaving Rodents under Acute and Chronic NMDA Receptor Antagonism

Sullivan, E. M., Timi, P., Hong, L. E., & O’Donnell, P. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.228 · Cited by 38 · see citing works

Subanesthetic Ketamine Treatment Promotes Abnormal Interactions between Neural Subsystems and Alters the Properties of Functional Brain Networks

Dawson, N., McDonald, M., Higham, D. J., MORRIS, B. J., & Pratt, J. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.26 · Cited by 37 · see citing works

Emerging Treatments in Schizophrenia

Correll, C. U., Abi‐Dargham, A., & Howes, O. D. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.su21024ip1 · Cited by 36 · see citing works

Mapping brain-behavior space relationships along the psychosis spectrum

Ji, J. L., Helmer, M., Fonteneau, C., Burt, J. B., Tamayo, Z., Demšar, J., Adkinson, B. D., Savić, A., Preller, K. H., Moujaes, F., et al. (2021) · eLife · doi:10.7554/elife.66968 · Cited by 38 · see citing works

Decreased Thalamocortical Connectivity in Chronic Ketamine Users

Liao, Y., Tang, J., Liu, J., Xie, A., Yang, M., Johnson, M., Wang, X., Deng, Q., Chen, H., Xiang, X., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167381 · Cited by 33 · see citing works

A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants

Abdallah, C. G., Ahn, K.-H., Averill, L. A., Nemati, S., Averill, C. L., Fouda, S., Ranganathan, M., MORGAN, P. T., D’Souza, D. C., Mathalon, D. H., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00864-9 · Cited by 33 · see citing works

Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review

Demchenko, I., Tassone, V. K., Kennedy, S. H., Dunlop, K., & Bhat, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.864902 · Cited by 29 · see citing works

How hot is the hot zone? Computational modelling clarifies the role of parietal and frontoparietal connectivity during anaesthetic-induced loss of consciousness

Ihalainen, R., Gosseries, O., de Steen, F. V., Raimondo, F., Panda, R., Bonhomme, V. L., Marinazzo, D., Bowman, H., Laureys, S., & Chennu, S. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.117841 · Cited by 31 · see citing works

Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans.Mol. Psychiatry 18, 1199–1204. doi: 10.1038/mp.2012.194 Ellison-Wright

Driesen, N. R., Ph., D., Mccarthy, G., Ph., D., Bhagwagar, Z., Ph., D., Ph., D., He, G., Ph., D., Ramach, R., et al. (2013)

Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System

Ćurić, S., Andreou, C., Nolte, G., Steinmann, S., Thiebes, S., Polomac, N., Haaf, M., Rauh, J., Leicht, G., & Mulert, C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.671007 · Cited by 31 · see citing works

Alterations in resting state electrocortical network oscillations, schizophrenia-like symptoms and their relationships induced with the administration of the NMDA receptor antagonist ketamine in human volunteers

Knott, V., de la Salle, S., McIntosh, J. F., Bowers, H., Shah, D. K., Choueiry, J., Beaudoin, A., Labelle, A., & Ilivitsky, V. (2021) · Psychiatry and Clinical Psychopharmacology

Resting-state functional EEG connectivity in salience and default mode networks and their relationship to dissociative symptoms during NMDA receptor antagonism

de la Salle, S., Choueiry, J., Shah, D. K., Bowers, H., McIntosh, J. F., Ilivitsky, V., Carroll, B., & Knott, V. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173092 · Cited by 9 · see citing works

A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms

Fleming, L. M., Javitt, D. C., Carter, C. S., Kantrowitz, J. T., Girgis, R. R., Kegeles, L. S., Ragland, J. D., Maddock, R. J., Lesh, T. A., Tanase, C., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101739 · Cited by 30 · see citing works